Understanding medical cannabis use internationally: Why definitions and context matter
Abstract Aims: To identify variation in identification of medical consumers using alternative self‐reported measures and assess whether differences in these…
Abstract Aims: To identify variation in identification of medical consumers using alternative self‐reported measures and assess whether differences in these…
Abstract There has been a global increase in the use of cannabinoids as a treatment for mental health (MH) and…
Abstract Background: An innovative New South Wales government funded statewide Cannabis Medicines Advisory Service (CMAS) operated between January 2018 and…
Abstract Background: Patient interest in the use of cannabis-based medicines (CBMs) has increased in Australia. While recent policy and legislative…
Abstract Cannabinoid co-administration may enable reduced opioid doses for analgesia. This updated systematic review on the opioid-sparing effects of cannabinoids…
Abstract There is international interest for consensus advice for prescribers working in the field of drug resistant epilepsy intending to…
Abstract Background: In 2018, an innovative, State government‐funded cannabis medicines drug information service was established for health professionals in New…